简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2017-07-24 15:19 People with idiopathic pulmonary fibrosis (IPF) reveal high burden of disease in new survey
2017-07-24 10:04 Mannatech Introduces the Most Advanced Ginseng Supplement in the World
2017-07-21 10:05 Together for Safer Roads Names David Braunstein As President
2017-07-18 16:08 Syneron Candela Completes Previously Announced Transaction with Funds Advised by Apax Partners and Becomes a Private Company
2017-07-17 14:08 Mannatech Makes the Morning Healthier with New Nutrient-Rich Coffee
2017-07-17 14:04 PSMF Convenes the International Patient Safety Community for its 2017 Midyear Planning Meeting at Inova Center for Personalized Health
2017-07-14 10:23 Discovery Platform Sparrho Raises $3M to Disrupt Scientific Research and Help Fuel Growth in China
2017-07-12 18:08 Octapharma Symposium At ISTH Berlin Supports Progress in Lifelong Treatment of High-Risk Patients With Von Willebrand Disease (VWD) and haemophilia A
2017-07-12 11:19 ISTH 2017, Berlin: Octapharma presents exciting Nuwiq® data in previously untreated patients and demonstrates real-life value of personalised prophylaxis for Haemophilia A
2017-07-11 18:10 The Broad Institute of MIT and Harvard Among Those Participating in MPEG LA’s CRISPR-Cas9 Joint Licensing Facilitation
2017-07-11 17:30 Final Phase III Study Results Confirm Benefit of Praxbind® as Reversal Agent for Pradaxa® Patients in Emergency Situations
2017-07-11 13:58 Masimo Announces CE Marking of rainbow® Super Sensor
2017-07-10 10:38 Octapharma Activities Prominent at the Upcoming 2017 ISTH Congress in Berlin, Germany
2017-07-10 10:35 Mannatech Brings Highest Grade Aloe Product in the World to China
2017-07-06 14:33 Zebra Medical Vision: First Artificial Intelligence Deployment at Scale to Improve Medical Imaging Diagnosis in 20 Developing Countries
2017-07-06 09:58 Celgene Corporation Enters Into Global Strategic Immuno-Oncology Collaboration with BeiGene to Advance PD-1 Inhibitor Program for Solid Tumor Cancers
2017-07-03 14:14 Ferring Appoints Lars Peter Brunse to Executive Board
2017-06-30 11:51 Takeda and Seattle Genetics Announce Positive Results from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma
2017-06-30 11:10 PSE Releases Significant gPROMS Processbuilder Update
2017-06-29 16:18 'More than Systemic Sclerosis: The Inside Story' – patients reveal the unseen impact of lung fibrosis